custom title

Banner description

Latest

News

Unitaid supports call for intellectual property waivers and action for access to COVID-19 products

Geneva – Unitaid calls on countries to take the necessary measures to facilitate and promote access to vaccines, therapeutics and diagnostics that will help fight the COVID-19 pandemic. This should include ensuring that they have the legal and health systems in place that enable fast production, importation, registration and deployment of effective products, once these become available. […]

Oct 14th, 2020
News

France gives extra US$11 million to support Unitaid work on COVID-19 therapies

Geneva – Unitaid is pleased to announce that France has contributed €10 million (US$11 million) to Unitaid’s work in the Therapeutics Partnership of the Access to COVID-19 Tools Accelerator (ACT-A). This is in addition to the core funding that France provides to Unitaid. The Therapeutics Partnership is co-convened by Unitaid alongside Wellcome. The two organisations are charged with leading […]

Oct 14th, 2020
News

Global partnership to make available 120 million affordable, quality COVID-19 rapid tests for low- and middle-income countries

Global partnership to make available 120 million affordable, quality COVID-19 rapid tests for low- and middle-income countries A full access package includes WHO policy guidance on the use of antigen-based rapid diagnostic tests, manufacturer volume guarantees for low and middle-income countries, catalytic funding to assist governments to deploy the tests and an initial US$50 million […]

Sep 30th, 2020